These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 15100287

  • 1. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y, Heeger PS, Valujskikh A.
    J Immunol; 2004 May 01; 172(9):5456-66. PubMed ID: 15100287
    [Abstract] [Full Text] [Related]

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.
    J Immunol; 2000 Sep 15; 165(6):3506-18. PubMed ID: 10975872
    [Abstract] [Full Text] [Related]

  • 3. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A, Fazekas de St Groth B, Wood KJ, Jones ND.
    J Immunol; 2004 Feb 15; 172(4):2163-70. PubMed ID: 14764682
    [Abstract] [Full Text] [Related]

  • 4. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y, Meng L, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2003 Mar 15; 170(6):3024-8. PubMed ID: 12626556
    [Abstract] [Full Text] [Related]

  • 5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 6. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW.
    J Immunol; 2008 Jul 15; 181(2):1096-102. PubMed ID: 18606661
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
    Yamada A, Salama AD, Sho M, Najafian N, Ito T, Forman JP, Kewalramani R, Sandner S, Harada H, Clarkson MR, Mandelbrot DA, Sharpe AH, Oshima H, Yagita H, Chalasani G, Lakkis FG, Auchincloss H, Sayegh MH.
    J Immunol; 2005 Feb 01; 174(3):1357-64. PubMed ID: 15661893
    [Abstract] [Full Text] [Related]

  • 9. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival.
    Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A.
    J Immunol; 2006 Jan 15; 176(2):770-7. PubMed ID: 16393960
    [Abstract] [Full Text] [Related]

  • 10. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2002 Oct 15; 169(8):4667-73. PubMed ID: 12370407
    [Abstract] [Full Text] [Related]

  • 11. Combination of monoclonal antibodies with DST inhibits accelerated rejection mediated by memory T cells to induce long-lived heart allograft acceptance in mice.
    Shao W, Chen J, Dai H, Peng Y, Wang F, Xia J, Thorlacius H, Zhu Q, Qi Z.
    Immunol Lett; 2011 Aug 30; 138(2):122-8. PubMed ID: 21477620
    [Abstract] [Full Text] [Related]

  • 12. B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.
    Gorbacheva V, Ayasoufi K, Fan R, Baldwin WM, Valujskikh A.
    Am J Transplant; 2015 Feb 30; 15(2):346-57. PubMed ID: 25496308
    [Abstract] [Full Text] [Related]

  • 13. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR, Wagener ME, Song M, Ford ML.
    PLoS One; 2012 Feb 30; 7(7):e40559. PubMed ID: 22792369
    [Abstract] [Full Text] [Related]

  • 14. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM, Ma L, Li Y, Yin D, Shen J, Xu J, Chong AS.
    J Immunol; 2009 Feb 01; 182(3):1314-24. PubMed ID: 19155477
    [Abstract] [Full Text] [Related]

  • 15. CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity.
    Rabant M, Gorbacheva V, Fan R, Yu H, Valujskikh A.
    Am J Transplant; 2013 Nov 01; 13(11):2831-2841. PubMed ID: 24102790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK, Chan Wood S, Eichwald EJ, Orosz CG.
    J Immunol; 2001 Mar 01; 166(5):3248-55. PubMed ID: 11207279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.